Found: 72
Select item for more details and to access through your institution.
Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide‐containing skincare.
- Published in:
- Journal of Cosmetic Dermatology, 2023, v. 22, n. 11, p. 2902, doi. 10.1111/jocd.15946
- By:
- Publication type:
- Article
Therapeutic application of machine learning in psoriasis: A Prisma systematic review.
- Published in:
- Journal of Cosmetic Dermatology, 2023, v. 22, n. 2, p. 378, doi. 10.1111/jocd.15122
- By:
- Publication type:
- Article
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 6, p. 613, doi. 10.1001/jamadermatol.2023.0846
- By:
- Publication type:
- Article
Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
OSTEOGENIC SARCOMA OF THE SCALP.
- Published in:
- International Journal of Dermatology, 1995, v. 34, n. 12, p. 861, doi. 10.1111/j.1365-4362.1995.tb04424.x
- By:
- Publication type:
- Article
MALIGNANT MELANOMA IN A TATTOO.
- Published in:
- 1993
- By:
- Publication type:
- Case Study
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 4, p. 669, doi. 10.1007/s40257-024-00855-2
- By:
- Publication type:
- Article
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 2, p. 305, doi. 10.1007/s40257-022-00739-3
- By:
- Publication type:
- Article
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 1, p. 93, doi. 10.1007/s40257-021-00650-3
- By:
- Publication type:
- Article
The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 6, p. 891, doi. 10.1007/s40257-020-00559-3
- By:
- Publication type:
- Article
Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Synergy and its clinical reievance in topical acne therapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Microsphere technology: hype or help?
- Published in:
- 2011
- By:
- Publication type:
- journal article
Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Efficacy and onset of action of hydrocortisone acetate 2.5% and pramoxine hydrochloride 1% lotion for the management of pruritus: results of a pilot study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2139, doi. 10.1007/s13555-024-01219-8
- By:
- Publication type:
- Article
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1211, doi. 10.1007/s13555-024-01155-7
- By:
- Publication type:
- Article
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 201, doi. 10.1007/s13555-023-01068-x
- By:
- Publication type:
- Article
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2016, v. 6, n. 4, p. 627, doi. 10.1007/s13555-016-0139-0
- By:
- Publication type:
- Article
708 - Raising the bar of efficacy in atopic dermatitis: lebrikizumab maintains depth of response over 2 years.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.082
- By:
- Publication type:
- Article
670 - Tapinarof cream 1% once daily is efficacious for the treatment of atopic dermatitis in patients with skin of color down to 2 years of age in two pivotal phase 3 trials.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.044
- By:
- Publication type:
- Article
640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.021
- By:
- Publication type:
- Article
Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii17, doi. 10.1093/bjd/ljad498.021
- By:
- Publication type:
- Article
Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii9, doi. 10.1093/bjd/ljad498.012
- By:
- Publication type:
- Article
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 4, p. 392, doi. 10.1093/bjd/ljad182
- By:
- Publication type:
- Article
Clinical and Legal Considerations in Pharmaceutical Compounding.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, p. S23
- By:
- Publication type:
- Article
Guidance on Documentation and Coding for Molluscum Contagiosum.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, p. S18
- By:
- Publication type:
- Article
Challenges in Psoriatic Disease Addressed by Fixed-Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, n. 3, p. 21
- By:
- Publication type:
- Article
Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Nonantibiotic Properties of Tetracyclines in Rosacea and Their Clinical Implications.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tetracyclines in Rosacea and Their Clinical Implications.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2021, v. 14, n. 8, p. 14
- By:
- Publication type:
- Article
Tazarotene 0.045% Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Preadolescent Patients: A Phase IV, Open-label, 12-week Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric Comorbidities.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Split-face, Controlled Study to Assess the Compatibility of Tretinoin 0.05% Acne Lotion with Facial Foundation Makeup.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2020, v. 13, n. 10, p. 11
- By:
- Publication type:
- Article
A Split-face, Controlled Study to Assess the Compatibility of Tretinoin 0.05% Acne Lotion with Facial Foundation Makeup.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to- Severe Papulopustular Rosacea.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2020, v. 13, n. 11, p. 44
- By:
- Publication type:
- Article
Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Topical Cantharidin in the Management of Molluscum Contagiosum: Preliminary Assessment of an Ether-free, Pharmaceutical-grade Formulation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% Cream.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rational Vehicle Design Ensures Targeted Cutaneous Steroid Delivery.
- Published in:
- 2017
- By:
- Publication type:
- journal article
United States Food and Drug Administration Product Label Changes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Oral Apremilast for the Treatment of Plaque Psoriasis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Secukinumab in the Treatment of Palmoplantar, Nail, Scalp, and Pustular Psoriasis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Secukinumab: Review of Clinical Evidence from the Pivotal Studies ERASURE, FIXTURE, and CLEAR.
- Published in:
- 2016
- By:
- Publication type:
- journal article